Neogenomics to buy Clarient By: MarketMinute.com Stock News October 21, 2015 at 18:02 PM EDT Neogenomics Inc. (Nasdaq: NEO) will acquire Clarient in a cash and stock deal valued at approximately $275 million. Neogenomics stock soared $1.40 to close at $7.08. Related Stocks: Neogenomics Inc